Sound Pharmaceuticals targets IPO in 2020 - (Puget Sound Business Journal via NewsPoints Desk)

  • Sound Pharmaceuticals is aiming to hold an initial public offering (IPO) next year, Puget Sound Business Journal reported Friday.

  • CEO Jonathan Kil indicated that the IPO could be valued at $100 million.

  • Sound, which has raised $37 million to date, has completed five clinical trials for three treatments.

  • The firm's most advanced asset, an experimental treatment for Meniere's disease, completed a Phase II study last month.

  • "We had individuals, after four weeks of treatment, who gained back 50 decibels of hearing," Kil stated, adding "you can only get that with a hearing aid."

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.

Reference Articles